Cargando…

Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values

We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Qui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niepsuj, Justyna, Franik, Grzegorz, Madej, Paweł, Piwowar, Agnieszka, Bizoń, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328171/ https://www.ncbi.nlm.nih.gov/pubmed/35884870 http://dx.doi.org/10.3390/biomedicines10071564

Ejemplares similares

Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

The Associations between Sex Hormones and Lipid Profiles in Serum of Women with Different Phenotypes of Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

The Activity of Superoxide Dismutase, Its Relationship with the Concentration of Zinc and Copper and the Prevalence of rs2070424 Superoxide Dismutase Gene in Women with Polycystic Ovary Syndrome—Preliminary Study
por: Bizoń, Anna, et al.
Publicado: (2022)

The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome
por: Kowalczyk, Karolina, et al.
Publicado: (2021)

Plasma sclerostin levels are associated with nutritional status and insulin resistance but not hormonal disturbances in women with polycystic ovary syndrome
por: Wyskida, Katarzyna, et al.
Publicado: (2020)

Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
por: Wyskida, Katarzyna, et al.
Publicado: (2020)

A cross-sectional study of the association between circulating sex hormone-binding globulin levels and selected adipokines in women with polycystic ovary syndrome
por: Ciura, Dariusz, et al.
Publicado: (2023)

Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
por: Blukacz, Łukasz, et al.
Publicado: (2022)

Correlation between Selected Clinical Symptoms and Severity of Aggression, Impulsiveness and Their Selected Behavioral Manifestations in Patients with Polycystic Ovary Syndrome Phenotype A
por: Barabasz-Gembczyk, Aleksandra, et al.
Publicado: (2023)

Total cholesterol/high-density lipoprotein and inflammatory parameters in patients with polycystic ovary syndrome
por: Gülücü, Selim, et al.
Publicado: (2022)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats
por: Salvetti, Natalia R, et al.
Publicado: (2009)

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome
por: Li, Wenqian, et al.
Publicado: (2022)

Prediction of Gut Microbial Community Structure and Function in Polycystic Ovary Syndrome With High Low-Density Lipoprotein Cholesterol
por: Zhu, Xuping, et al.
Publicado: (2021)

The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
por: Rahimi, Zohreh, et al.
Publicado: (2018)

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
por: Jabczyk, Marzena, et al.
Publicado: (2023)

Bone mineral density in women with polycystic ovary syndrome
por: Katulski, K., et al.
Publicado: (2014)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
por: Xiang, Shou-Kui, et al.
Publicado: (2012)

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome
por: Song, Do Kyeong, et al.
Publicado: (2016)

Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome
por: Kumar, D. Rama Nagendra, et al.
Publicado: (2017)

Evaluation of Adipokines, Inflammatory Markers, and Sex Hormones in Simple and Complex Breast Cysts' Fluid
por: Madej, Paweł, et al.
Publicado: (2016)

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
por: Bednarz, Krzysztof, et al.
Publicado: (2022)

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
por: Kyaw Tun, Tommy, et al.
Publicado: (2016)

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome
por: Abazar, Elaheh, et al.
Publicado: (2015)

Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing–Remitting Multiple Sclerosis
por: Bizoń, Anna, et al.
Publicado: (2023)

Uptake of lipoproteins by in situ perfused rat ovaries: identification of binding sites for high density lipoproteins
Publicado: (1983)

Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome
por: Zhang, Chen-Hua, et al.
Publicado: (2023)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Evaluation of Selected Oxidant/Antioxidant Parameters in Patients with Relapsing-Remitting Multiple Sclerosis Undergoing Disease-Modifying Therapies
por: Bizoń, Anna, et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes
por: Polak, Aleksandra Maria, et al.
Publicado: (2020)

Anxiety and Depression in Women with Polycystic Ovary Syndrome
por: Dybciak, Paweł, et al.
Publicado: (2022)

Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome
por: Zaki, Moushira, et al.
Publicado: (2017)

Role of Sirtuins in Physiology and Diseases of the Central Nervous System
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2022)

Complex formation constant of ferric ion with Gly, Pro-Hyp and Gly-Pro-Hyp
por: Zhi, Mingyu, et al.
Publicado: (2018)

The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome
por: Biernacka-Bartnik, Aleksandra, et al.
Publicado: (2023)

Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome
por: Adamska, Agnieszka, et al.
Publicado: (2019)

Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
por: Adamczak, Agnieszka, et al.
Publicado: (2023)

Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
por: Biernacka-Bartnik, Aleksandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ibtc41voif7tqdp3agoh6ljefs